What's new

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2025, 14:00 (CEST) to 14 October 2025, 15:00 (CEST)

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2025, 14:00 (CEST) to 14 October 2025, 15:00 (CEST)

Jun 26, 2025 - 13:50
 0
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2025, 14:00 (CEST) to 14 October 2025, 15:00 (CEST)
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2025, 14:00 (CEST) to 14 October 2025, 15:00 (CEST)
Read More

Tags:

Previous Article

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) serv...

Next Article

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) serv...

Related Posts

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

Human medicines European public assessment report (EPAR): Teysuno, tegafur,gimeracil,oteracil, Date of authorisation: 14/03/2011, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0

Human medicines European public assessment report (EPAR): TachoSil, human fibrinogen,human thrombin, Date of authorisation: 08/06/2004, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 17, 2025  0